PATRICK FOY, MD
Hematology & Oncology Physician in MILWAUKEE, Wisconsin. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
PATRICK FOY, MD reported a CMS MIPS final score of 80.4671/100 — below the 83.1 national average — and filed 412 Medicare Part D claims in 2023.
- 80.4671/100
- MIPS score · -3 vs avg
- 412
- Part D claims, 2023
- 44%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
PATRICK FOY, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
80 33rd percentile higher than 33% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
PATRICK FOY, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about PATRICK FOY, MD?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Wisconsin
How Hematology & Oncology Physician compares to other specialties among Wisconsin providers
Hematology & Oncology Physician share within Wisconsin
Hematology & Oncology Physician is one of the more visible NUCC categories in Wisconsin
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
PATRICK FOY, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 80.4671/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Hematology & Oncology Physician) — 80.4671/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Hematology & Oncology Physician US NPIs
80.4671/100 MIPS final score — 2.6 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Hematology & Oncology Physician. Quality dim: 66.2426. Cost dim: 68.6477.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
PATRICK FOY, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 9200 W WISCONSIN AVE, MILWAUKEE, WI, 53226, with a listed phone of (414) 805-6800. NPI 1366634040 was issued on 08/15/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FOY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 412 prescription claims written by this provider, covering 101 Medicare beneficiaries and totaling roughly $1.2 million in drug spend, split 56% brand-name and 44% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 80.4671/100 for the 2023 performance year (Quality 66.2426, Cost 68.6477), compared with the national average of 83.1.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1366634040 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 08/15/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm PATRICK FOY, MD's current license status, disciplinary history, and board certifications with the Wisconsin Department of Safety and Professional Services in Wisconsin before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where PATRICK FOY, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for PATRICK FOY, MD. Source: openpaymentsdata.cms.gov.
Total received
$40.7K
Largest payer
Alexion Pharmaceuticals, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
56% brand-name claims vs 44% generic, on 412 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 775
- Total Day Supply
- 22,732
- Brand vs Generic
- 56% brand / 44% generic
- Brand Drug Cost
- $1.2M
- Generic Drug Cost
- $24K
Patient Demographics
- Average Patient Age
- 69.2 years
- Avg HCC Risk Score
- 2.60
- Gender Split
- 49% female / 51% male
- Age Distribution
- <65: 27, 65-74: 40, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What PATRICK FOY, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Eliquis
Eliquis
102 claims
- Hydroxyurea
Hydroxyurea
78 claims
- Xarelto
Xarelto
62 claims
- Jakafi 40
Jakafi
40 claims
- Warfarin Sodium 25
Warfarin Sodium
25 claims
- Tranexamic Acid 11
Tranexamic Acid
11 claims
| Drug | Claims |
|---|---|
| Eliquis Apixaban | 102 |
| Hydroxyurea | 78 |
| Xarelto Rivaroxaban | 62 |
| Jakafi Ruxolitinib Phosphate | 40 |
| Warfarin Sodium | 25 |
| Tranexamic Acid | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How PATRICK FOY, MD fits within the Hematology & Oncology Physician landscape nationally.
PATRICK FOY, MD's 412 claims are below the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in Wisconsin
Other clinicians with the same primary specialty enrolled in Wisconsin, drawn from the same CMS NPPES roster as FOY.
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Wisconsin
Frequently Asked Questions
What is PATRICK FOY, MD's specialty? ▼
How much does PATRICK FOY, MD prescribe under Medicare Part D? ▼
What is PATRICK FOY, MD's Medicare quality score? ▼
Where is PATRICK FOY, MD located? ▼
What is PATRICK FOY, MD's NPI number? ▼
Does PATRICK FOY, MD prescribe more brand-name or generic drugs? ▼
How many Hematology & Oncology Physician providers are there in the US? ▼
What drugs does PATRICK FOY, MD prescribe most often? ▼
Does PATRICK FOY, MD accept Medicare? ▼
How can I verify PATRICK FOY, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology